Most Popular
1. It’s a New Macro, the Gold Market Knows It, But Dead Men Walking Do Not (yet)- Gary_Tanashian
2.Stock Market Presidential Election Cycle Seasonal Trend Analysis - Nadeem_Walayat
3. Bitcoin S&P Pattern - Nadeem_Walayat
4.Nvidia Blow Off Top - Flying High like the Phoenix too Close to the Sun - Nadeem_Walayat
4.U.S. financial market’s “Weimar phase” impact to your fiat and digital assets - Raymond_Matison
5. How to Profit from the Global Warming ClImate Change Mega Death Trend - Part1 - Nadeem_Walayat
7.Bitcoin Gravy Train Trend Forecast 2024 - - Nadeem_Walayat
8.The Bond Trade and Interest Rates - Nadeem_Walayat
9.It’s Easy to Scream Stocks Bubble! - Stephen_McBride
10.Fed’s Next Intertest Rate Move might not align with popular consensus - Richard_Mills
Last 7 days
Stock Market Brief in Count Down to US Election Result 2024 - 3rd Nov 24
Gold Stocks’ Winter Rally 2024 - 3rd Nov 24
Why Countdown to U.S. Recession is Underway - 3rd Nov 24
Stock Market Trend Forecast to Jan 2025 - 2nd Nov 24
President Donald PUMP Forecast to Win US Presidential Election 2024 - 1st Nov 24
At These Levels, Buying Silver Is Like Getting It At $5 In 2003 - 28th Oct 24
Nvidia Numero Uno Selling Shovels in the AI Gold Rush - 28th Oct 24
The Future of Online Casinos - 28th Oct 24
Panic in the Air As Stock Market Correction Delivers Deep Opps in AI Tech Stocks - 27th Oct 24
Stocks, Bitcoin, Crypto's Counting Down to President Donald Pump! - 27th Oct 24
UK Budget 2024 - What to do Before 30th Oct - Pensions and ISA's - 27th Oct 24
7 Days of Crypto Opportunities Starts NOW - 27th Oct 24
The Power Law in Venture Capital: How Visionary Investors Like Yuri Milner Have Shaped the Future - 27th Oct 24
This Points To Significantly Higher Silver Prices - 27th Oct 24
US House Prices Trend Forecast 2024 to 2026 - 11th Oct 24
US Housing Market Analysis - Immigration Drives House Prices Higher - 30th Sep 24
Stock Market October Correction - 30th Sep 24
The Folly of Tariffs and Trade Wars - 30th Sep 24
Gold: 5 principles to help you stay ahead of price turns - 30th Sep 24
The Everything Rally will Spark multi year Bull Market - 30th Sep 24
US FIXED MORTGAGES LIMITING SUPPLY - 23rd Sep 24
US Housing Market Free Equity - 23rd Sep 24
US Rate Cut FOMO In Stock Market Correction Window - 22nd Sep 24
US State Demographics - 22nd Sep 24
Gold and Silver Shine as the Fed Cuts Rates: What’s Next? - 22nd Sep 24
Stock Market Sentiment Speaks:Nothing Can Topple This Market - 22nd Sep 24
US Population Growth Rate - 17th Sep 24
Are Stocks Overheating? - 17th Sep 24
Sentiment Speaks: Silver Is At A Major Turning Point - 17th Sep 24
If The Stock Market Turn Quickly, How Bad Can Things Get? - 17th Sep 24
IMMIGRATION DRIVES HOUSE PRICES HIGHER - 12th Sep 24
Global Debt Bubble - 12th Sep 24
Gold’s Outlook CPI Data - 12th Sep 24

Market Oracle FREE Newsletter

How to Protect your Wealth by Investing in AI Tech Stocks

Here’s How Pharma Is Using AI Deep Learning To Cure Aging

Companies / AI Mar 16, 2017 - 10:20 AM GMT

By: John_Mauldin

Companies

BY PATRICK COX : In 2011, scientists made one of the most important discoveries in the history of AI development. They found that graphics processing units (GPUs) are far better at simulating biological learning than central processing units (CPUs).

In retrospect, it seems obvious. Human brains are much more like GPUs than CPUs. Both brains and GPUs rely on parallel processing that simulates and predicts real world physics.


In light of this, AI developers created powerful deep neural networks (DNNs) that emulate human brain function. All the major advances in self-driving cars and language translation are the result of this.

Below is a chart from Nvidia. It shows the explosive progress of AI running the Caffe deep learning platform:

In the meantime, pharma is tapping into this breakthrough to cure the diseases of aging and cut healthcare costs.

Deep Learning and Aging

One company that took on aging is InSilico Medicine. InSilico is one of the biotech companies I write about in my weekly publication, Tech Digest (subscribe here for free). The company uses DNNs to sort through huge amounts of biological data. The DNNs look for biomarkers (measurable indicators of your biological state such as those included in blood tests) that correlate with aging. For humans, this would be an impossibly complicated and time-consuming task.

InSilico has developed a program that will guess your age within a few years based on a standard blood test. Why should you care?

The reason is that biomarkers indicating old age can be altered. We can identify compounds that can make your biomarkers—and you—younger and healthier. A few of these compounds are already known. But scientists lacked the technology to identify the most powerful ones... until now.

Today, there is a race to find the most effective and safest geroprotectors. These are compounds that can restore you and your biomarkers to a more youthful profile.

One player in this field is the Life Extension Foundation (LEF). It’s on a mission to find safe and effective natural geroprotectors without regulatory delays and costs.

Last week, InSilico Medicine announced a product called Ageless Cell. It was developed in collaboration with LEF’s head of R&D Andrew Swick, PhD, former Director of Cardiovascular and Metabolic Diseases at Pfizer Global Research and Development. The supplement contains four natural compounds that DNNs have shown can rejuvenate older cells.

LEF has access to blood tests from its customers who take the product. That means data should be available in less than a year. If it works, we can expect other DNN-developed geroprotectors.

Investment Implications

Many biotech companies, including startups, are using AI. That means investors can bet on this trend without exposure to the volatility of biotech startups.

Nvidia (NVDA) is the obvious way to play the growth of DNN applications. The company may have been overvalued at one point, but several negative reports drove its price back to bargain levels.

One indication of the potential of this company comes from Insilico Medicine’s CEO. He told me that the company ran calculations for the LEF supplement on a 40 Tflop 4xNvidia Titan X (Pascal architecture) supercomputer. Since then, Insilico built another GPU cluster using 16xTitan X (Pascal), delivering 160 Tflops in GPU computing power. 

Despite a collaborative relationship with Nvidia, Insilico couldn’t get all the Nvidia GPUs it needed for the project due to high demand for the processors. This points to strong growth potential in this market.

While Nvidia pioneered dedicated GPUs for AI, chip giant Intel (INTC) is catching up. Last year, Intel bought AI startup Nervana and integrated its deep learning architecture into Xeon microprocessors. Intel also benefits from an arrangement with Google to advance AI in multicloud environments.

One tech giant that doesn’t seem to be riding this wave is IBM. Big Blue made a big mistake by underestimating the market for AI computer components. Instead, IBM invested in its own cognitive system called Watson. IBM may expand its AI product line, but we’ll have to see if the shift comes in time to compete with Nvidia and Intel.

In any case, advanced AI is not just a marginal improvement in analytical tools. It’s the only technology capable of exploiting the massive knowledge gained from human genome sequencing.

Stay in the Loop on Life-Extending Research with Patrick Cox's Tech Digest

This weekly newsletter by biotech expert Patrick Cox highlights research that is much more advanced than most people know, and the profit potential for investors is vast. Read about the latest breakthroughs—from new, non-invasive cancer treatments to age-reversing nutraceuticals and vaccines that kill any virus–as well as the innovative companies that work on them. Get Tech Digest free in your inbox every Monday.

John Mauldin Archive

© 2005-2022 http://www.MarketOracle.co.uk - The Market Oracle is a FREE Daily Financial Markets Analysis & Forecasting online publication.


Post Comment

Only logged in users are allowed to post comments. Register/ Log in